You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 5,432,055


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,432,055
Title: Detection of Porphyromonas gingivalis
Abstract:The present invention relates to novel compositions comprising P. gingivalis specific oligonucleotides which are useful as primers to amplify particular regions of the genome of P. gingivalis during enzymatic nucleic acid amplification. The invention also provides a method for the detection of P. gingivalis, which may be present in a clinical specimen, using the P. gingivalis-specific primers and enzymatic nucleic acid amplification. The present invention also relates to P. gingivalis-specific oligonucleotides which are useful as probes to facilitate detection of the amplified regions of P. gingivalis DNA.
Inventor(s): Evans; Mary J. (East Amherst, NY), Evans; Richard T. (East Amherst, NY), Genco; Robert J. (Buffalo, NY), Greenberg; Steven J. (Orchard Park, NY), Kuramitsu; Howard K. (Clarence, NY)
Assignee:
Application Number:08/072,067
Patent Claims:1. A composition, for the detection of Porphyromonas gingivalis, consisting essentially of a purified and isolated oligonucleotide consisting of a nucleic acid sequence which complements and specifically hybridizes to a conserved region of a P. gingivalis gene selected from the group consisting of the fimbrial gene, superoxide dismutase gene, and collagenase gene, wherein said sequence is selected from the group consisting of:

SEQ ID No: 1--TTTGGAGTTG GCGATGACGA A;

SEQ ID No: 2--GCTTTTACCT CTGCAAGAGT C;

SEQ ID No: 3--AAGGTGGCTA AGTTGACCGT AATGGTTTAT AATGGAGAAC A;

SEQ ID No: 4--ATTTCCCTGC CTTATGCGGT CGATGCACTG GCTCCTGTTA;

SEQ ID No: 5--ACGATTCTGG TAAGTCAGAT AATATGCGTG CTCCCATGC;

SEQ ID No: 6--TCATTCGAAAAGTTCAAAGA GGAGTTCAAC ACAGCCGGTA;

SEQ ID No: 7--ATCTGTCCAC TCAGCTCAAT ATCAGCAATG CGGAAGCCCT A;

SEQ ID No: 8--ATCCATCATC TTATTGATGAAATGAATAGT CTT; and

SEQ ID No: 9--AAGTGCTATC TAAGCCTGCA CGAACACAA.

2. A method for detecting the presence or absence of Porphyromonas gingivalis, wherein the method comprises the steps of:

(a) lysing the cells in a specimen to release bacterial nucleic acid molecules;

(b) contacting the nucleic acid molecules with oligonucleotides SEQ ID No: 1 and SEQ ID No: 2 of claim 1 under suitable conditions permitting hybridization of the oligonucleotides to the nucleic acid molecules;

(c) enzymatically amplifying a specific region of the nucleic acid molecules comprising target sequences of the P. gingivalis fimbrial gene using oligonucleotides SEQ ID No: 1 and SEQ ID No: 2 as primers;

(d) detecting the presence of amplified target sequences of approximately 203 nucleotides in length, wherein the presence of the amplified target sequences correlates to the presence of P. gingivalis in the specimen.

3. The method of claim 2, wherein the detection step is performed by labelling at least one of the oligonucleotides with a detectable moiety.

4. The method of claim 2, wherein the detection step is performed by hybridization of the amplified target sequences with oligonucleotide SEQ ID No: 3 as a probe.

5. The method of claim 4, wherein the detection step is performed by labelling the oligonucleotide probe with a detectable moiety.

6. A method for detecting the presence or absence of Porphyromonas gingivalis, wherein the method comprises the steps of:

(a) lysing the cells in a specimen to release bacterial nucleic acid molecules;

(b) contacting the nucleic acid molecules with oligonucleotides SEQ ID No: 4 and SEQ ID No: 5 of claim 1 under suitable conditions permitting hybridization of the oligonucleotides to the nucleic acid molecules;

(c) enzymatically amplifying a specific region of the nucleic acid molecules comprising target sequences of the P. gingivalis superoxide dismutase gene using oligonucleotides SEQ ID No: 4 and SEQ ID No: 5 as primers;

(d) detecting the presence of amplified target sequences of approximately 493 nucleotides in length, wherein the presence of the amplified target sequences correlates to the presence of P. gingivalis in the specimen.

7. The method of claim 6, wherein the detection step is performed by labelling at least one of the oligonucleotides with a detectable moiety.

8. The method of claim 6, wherein the detection step is performed by hybridization of the amplified target sequences with oligonucleotide SEQ ID No: 6 as a probe.

9. The method of claim 8, wherein the detection step is performed by labelling the oligonucleotide probe with a detectable moiety.

10. A method for detecting the presence or absence of Porphyromonas gingivalis, wherein the method comprises the steps of:

(a) lysing the cells in a specimen to release bacterial nucleic acid molecules;

(b) contacting the nucleic acid molecules with oligonucleotides SEQ ID No: 7 and SEQ ID No: 8 of claim 1 under suitable conditions permitting hybridization of the oligonucleotides to the nucleic acid molecules;

(c) enzymatically amplifying a specific region of the nucleic acid molecules comprising target sequences of the P. gingivalis collagenase gene using oligonucleotides SEQ ID No: 7 and SEQ ID No: 8 as primers;

(d) detecting the presence of amplified target sequences of approximately 381 nucleotides in length, wherein the presence of the amplified target sequences correlates to the presence of P. gingivalis in the specimen.

11. The method of claim 10, wherein the detection step is performed by labelling at least one of the oligonucleotides with a detectable moiety.

12. (Amended) The method of claim 10, wherein the detection step is performed by hybridization of the amplified target sequences with oligonucleotide SEQ ID No: 9 as a probe.

13. The method of claim 12, wherein the detection step is performed by labelling the oligonucleotide probe with a detectable moiety.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.